The Potential Safe Antifibrotic Effect of Stem Cell Conditioned Medium and Nilotinib Combined Therapy by Selective Elimination of Rat Activated HSCs

Antifibrotic Effect of Combination of Nilotinib and Stem Cell-Conditioned Media on CCl4-Induced Liver Fibrosis

(2020) Gamal Shiha et al.   Stem Cells International

Zinc Oxide Nanoparticle Synergizes Sorafenib Anticancer Efficacy with Minimizing Its Cytotoxicity

(2020) Ahmed Nabil et al.   Oxidative Medicine and Cellular Longevity

Strategies to improve the efficiency of mesenchymal stem cell transplantation for reversal of liver fibrosis

(2019) Chenxia Hu et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Kenalog modified by ionizing radiation induces intrinsic apoptosis mediated by elevated levels of reactive oxygen species in melanoma cancer

(2018) Remigius Kawala et al.   ONCOLOGY REPORTS

Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice

(2015) Raphael P.H. Meier et al.   JOURNAL OF HEPATOLOGY

Use of mesenchymal stem cells to treat liver fibrosis: Current situation and future prospects

(2015) Silvia Berardis et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Colloidal Drug Formulations Can Explain “Bell-Shaped” Concentration–Response Curves

(2014) Shawn C. Owen et al.   ACS Chemical Biology

Tracking anti-fibrotic pathways of nilotinib and imatinib in experimentally induced liver fibrosis: An insight

(2014) Gamal E Shiha et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Human liver stem cells improve liver injury in a model of fulminant liver failure

(2012) Maria Beatriz Herrera et al.   HEPATOLOGY

Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials

(2012) Manoj M. Lalu et al.   PLoS One

The Phenotypic Characteristic of Liver-Derived Stem Cells From Adult Human Deceased Donor Liver

(2012) J.-H. Lee et al.   TRANSPLANTATION PROCEEDINGS

Anti-fibrogenic strategies and the regression of fibrosis

(2011) Tatiana Kisseleva et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Comparison of early treatment with low doses of nilotinib, imatinib and a clinically relevant dose of silymarin in thioacetamide-induced liver fibrosis

(2011) Mohamed E. Shaker et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Inhibition of PDGF, TGF-β, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib

(2011) Yuqing Liu et al.   JOURNAL OF HEPATOLOGY

Activation of Notch1 signaling by marrow-derived mesenchymal stem cells through cell–cell contact inhibits proliferation of hepatic stellate cells

(2011) Si Chen et al.   LIFE SCIENCES

Safety and Immunological Effects of Mesenchymal Stem Cell Transplantation in Patients With Multiple Sclerosis and Amyotrophic Lateral Sclerosis

(2010) Dimitrios Karussis et al.   ARCHIVES OF NEUROLOGY

Atorvastatin induces apoptosis by a caspase-9-dependent pathway: an in vitro study on activated rat hepatic stellate cells

(2010) Isabella Aprigliano et al.   LIVER INTERNATIONAL

Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib

(2008) Elizabeth Day et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis

(2008) Alfiya Akhmetshina et al.   FASEB JOURNAL

Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regenerationin vitroandin vivo

(2008) Daan van Poll et al.   HEPATOLOGY

Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver

(2008) Scott L. Friedman   PHYSIOLOGICAL REVIEWS